目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Separation Systems for Commercial Biotechnology Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Separation Systems for Commercial Biotechnology Market: Method Movement Analysis, 2023 & 2030 (USD Million)
4.3. Conventional Methods
4.3.1. Conventional Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Chromatography
4.3.2.1. Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Flow Cytometry
4.3.3.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Membrane Filtration
4.3.4.1. Membrane Filtration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Electrophoresis
4.3.5.1. Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Centrifugation
4.3.6.1. Centrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Modern Methods
4.4.1. Modern Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Microarray
4.4.2.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Lab-on-a-chip
4.4.3.1. Lab-on-a-chip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Magnetic Separation
4.4.4.1. Magnetic Separation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Biochip
4.4.5.1. Biochip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Separation Systems for Commercial Biotechnology Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Pharmaceutical
5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Vaccines
5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Proteins
5.3.3.1. Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Hormones/Insulin
5.3.4.1. Hormones/Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Enzymes
5.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Human Blood Plasma Fractionation
5.3.6.1. Human Blood Plasma Fractionation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Mammalian Cell Cultures
5.3.7.1. Mammalian Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Food & Cosmetics
5.4.1. Food & Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Agriculture
5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis
6.1. Separation Systems for Commercial Biotechnology Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Thermo Fisher Scientific Inc.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/Strategic Initiatives
7.4.2. QIAGEN
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/Strategic Initiatives
7.4.3. Horizon Discovery Ltd.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/Strategic Initiatives
7.4.4. OriGene Technologies, Inc.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/Strategic Initiatives
7.4.5. Oxford Biomedica PLC
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/Strategic Initiatives
7.4.6. SignaGen Laboratories
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/Strategic Initiatives
7.4.7. Flash Therapeutics
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/Strategic Initiatives
7.4.8. Takara Bio Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/Strategic Initiatives
7.4.9. Bio-Rad Laboratories, Inc.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/Strategic Initiatives
7.4.10. System Biosciences, LLC.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/Strategic Initiatives
7.4.11. Promega Corporation
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/Strategic Initiatives
7.4.12. F. Hoffmann-La Roche Ltd
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/Strategic Initiatives
7.4.13. Revvity
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/Strategic Initiatives
7.4.14. Catalent, Inc
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/Strategic Initiatives